Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | PFDN2 |
| Upstream (Parents) |
|---|
| (<<) CCNB2 → PFDN2 |
| (<<) CCNE1 → PFDN2 |
| (<<) CDKN2A → PFDN2 |
| (<<) CEBPB → PFDN2 |
| (<<) DHRS9 → PFDN2 |
| (<<) DNM1L → PFDN2 |
| (<<) E2F3 → PFDN2 |
| (<<) KIAA0020 → PFDN2 |
| (<<) MLPH → PFDN2 |
| (<<) UBE2C → PFDN2 |
| Downstream (Children) |
|---|
| PFDN2 → ADAM15 (>>) |
| PFDN2 → AKT1 (>>) |
| PFDN2 → ANKRD27 (>>) |
| PFDN2 → BCL2 (>>) |
| PFDN2 → CALML5 (>>) |
| PFDN2 → CCNB1 (>>) |
| PFDN2 → CHODL (>>) |
| PFDN2 → CNIH4 (>>) |
| PFDN2 → DLAT (>>) |
| PFDN2 → DUSP2 (>>) |
| PFDN2 → EFNB1 (>>) |
| PFDN2 → EIF4EBP1 (>>) |
| PFDN2 → ELF5 (>>) |
| PFDN2 → ELOVL1 (>>) |
| PFDN2 → EMG1 (>>) |
| PFDN2 → FAM136A (>>) |
| PFDN2 → GAL (>>) |
| PFDN2 → GAPDH (>>) |
| PFDN2 → GNAQ (>>) |
| PFDN2 → HBEGF (>>) |
| PFDN2 → HDAC2 (>>) |
| PFDN2 → HSPA14 (>>) |
| PFDN2 → HSPC159 (>>) |
| PFDN2 → JUN (>>) |
| PFDN2 → MAP2K2 (>>) |
| PFDN2 → MAPKAPK5 (>>) |
| PFDN2 → MRAS (>>) |
| PFDN2 → MT1P2 (>>) |
| PFDN2 → MTAP (>>) |
| PFDN2 → MUC2 (>>) |
| PFDN2 → MYC (>>) |
| PFDN2 → NET1 (>>) |
| PFDN2 → NFIB (>>) |
| PFDN2 → NMU (>>) |
| PFDN2 → NXT1 (>>) |
| PFDN2 → PDIA4 (>>) |
| PFDN2 → PHLDA2 (>>) |
| PFDN2 → PRDX6 (>>) |
| PFDN2 → PTK7 (>>) |
| PFDN2 → RAC3 (>>) |
| PFDN2 → RPL35 (>>) |
| PFDN2 → RPS16 (>>) |
| PFDN2 → RRP1 (>>) |
| PFDN2 → RRP9 (>>) |
| PFDN2 → RYK (>>) |
| PFDN2 → SESN1 (>>) |
| PFDN2 → SHFM1 (>>) |
| PFDN2 → SMAD1 (>>) |
| PFDN2 → SMTN (>>) |
| PFDN2 → SOCS2 (>>) |
| PFDN2 → STAT3 (>>) |
| PFDN2 → TAF1A (>>) |
| PFDN2 → TAGLN2 (>>) |
| PFDN2 → TCOF1 (>>) |
| PFDN2 → TEX10 (>>) |
| PFDN2 → TUBA1C (>>) |
| PFDN2 → UAP1 (>>) |
| PFDN2 → VEGFA (>>) |
| PFDN2 → WNT5B (>>) |
| PFDN2 → YWHAH (>>) |
| PFDN2 → YWHAZ (>>) |
| PFDN2 → ZNF750 (>>) |
